Edition:
United Kingdom

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

3.96USD
8:10pm GMT
Change (% chg)

$0.08 (+2.06%)
Prev Close
$3.88
Open
$3.88
Day's High
$4.01
Day's Low
$3.80
Volume
17,286
Avg. Vol
21,450
52-wk High
$8.55
52-wk Low
$3.37

Chart for

About

Cidara Therapeutics, Inc., formerly K2 Therapeutics, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery, development and commercialization of anti-infectives. It is developing a pipeline of product and development candidates with a focus on serious fungal infections. Its product portfolio... (more)

Overall

Beta: --
Market Cap(Mil.): $123.10
Shares Outstanding(Mil.): 16.86
Dividend: --
Yield (%): --

Financials

  CDTX.OQ Industry Sector
P/E (TTM): -- 85.49 33.64
EPS (TTM): -3.55 -- --
ROI: -72.93 -0.29 14.22
ROE: -77.58 0.40 15.99

BRIEF-Cidara Announces Stock And Warrants Offering Worth $120 Mln

* CIDARA THERAPEUTICS ANNOUNCES OFFERING OF COMMON STOCK AND WARRANTS

21 May 2018

Earnings vs. Estimates